Literature DB >> 20149737

Denosumab: a breakthrough in treatment of giant-cell tumour of bone?

Maurice Balke, Jendrik Hardes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20149737     DOI： 10.1016/S1470-2045(10)70027-9

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  10 in total

1.  Giant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets.

Authors:  Noah Federman; Earl W Brien; Vivek Narasimhan; Sarah M Dry; Monish Sodhi; Sant P Chawla
Journal:  Paediatr Drugs       Date:  2014-02       Impact factor: 3.022

Review 2.  Denosumab and giant cell tumour of bone-a review and future management considerations.

Authors:  S F Xu; B Adams; X C Yu; M Xu
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

3.  Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.

Authors:  Bharat Rekhi; Vivek Verma; Ashish Gulia; Nirmala A Jambhekar; Subhash Desai; Shashikant L Juvekar; Jyoti Bajpai; Ajay Puri
Journal:  Pathol Oncol Res       Date:  2016-10-08       Impact factor: 3.201

4.  Preoperative Denosumab With Curettage and Cryotherapy in Giant Cell Tumor of Bone: Is There an Increased Risk of Local Recurrence?

Authors:  Guido Scoccianti; Francesca Totti; Maurizio Scorianz; Giacomo Baldi; Giuliana Roselli; Giovanni Beltrami; Alessandro Franchi; Rodolfo Capanna; Domenico Andrea Campanacci
Journal:  Clin Orthop Relat Res       Date:  2018-09       Impact factor: 4.176

5.  Protein Expression Profiling of Giant Cell Tumors of Bone Treated with Denosumab.

Authors:  Kenta Mukaihara; Yoshiyuki Suehara; Shinji Kohsaka; Keisuke Akaike; Yu Tanabe; Daisuke Kubota; Midori Ishii; Tsutomu Fujimura; Saiko Kazuno; Taketo Okubo; Tatsuya Takagi; Takashi Yao; Kazuo Kaneko; Tsuyoshi Saito
Journal:  PLoS One       Date:  2016-02-10       Impact factor: 3.240

Review 6.  A large giant cell tumor of the larynx: case report and review of the literature.

Authors:  Andrew Arndt; Rachelle LeBlanc; Peter Spafford
Journal:  J Otolaryngol Head Neck Surg       Date:  2017-04-04

7.  Custom 3D-printed finger proximal phalanx as salvage of limb function after aggressive recurrence of giant cell tumour.

Authors:  Giovanni Beltrami
Journal:  BMJ Case Rep       Date:  2018-09-18

8.  Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial.

Authors:  Shenglong Li; Peng Chen; Qiankun Yang
Journal:  J Bone Oncol       Date:  2019-01-23       Impact factor: 4.072

9.  Denosumab versus zoledronic acid in cases of surgically unsalvageable giant cell tumor of bone: A randomized clinical trial.

Authors:  Jiaji Yue; Wei Sun; Shenglong Li
Journal:  J Bone Oncol       Date:  2022-06-24       Impact factor: 4.491

10.  Isocitrate dehydrogenase mutation is frequently observed in giant cell tumor of bone.

Authors:  Mika Kato Kaneko; Xing Liu; Hiroharu Oki; Satoshi Ogasawara; Takuro Nakamura; Noriko Saidoh; Yuta Tsujimoto; Yuka Matsuyama; Akira Uruno; Masato Sugawara; Takashi Tsuchiya; Mitsunori Yamakawa; Masayuki Yamamoto; Michiaki Takagi; Yukinari Kato
Journal:  Cancer Sci       Date:  2014-06       Impact factor: 6.716
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.